Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Grant or award CEO acquired 50,000 shares (grant or award)
  2. 4 Open-market sale EVP, CBO AND CTO sold 101 shares at $8.89 ($898)
  3. 4 Open-market sale EVP, CHIEF SCIENTIFIC OFFICER sold 2,790 shares at $9.67 ($26,966)
  4. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 4,287 shares at $9.67 ($41,435)
  5. 4 Open-market sale EVP, CBO AND CTO sold 3,307 shares at $9.67 ($31,963)
  6. 4 Open-market sale EVP, CBO AND CTO sold 346 shares at $11.10 ($3,841)
  7. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 1,752 shares at $8.16 ($14,296)
  8. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 193 shares at $10.23 ($1,974)
  9. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 102 shares at $10.23 ($1,043)
  10. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 289 shares at $11.02 ($3,185)
  11. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 192 shares at $15.01 ($2,882)
  12. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 101 shares at $15.01 ($1,516)
  13. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 293 shares at $18.60 ($5,449)
  14. 4 Grant or award SVP, CHIEF MEDICAL OFFICER acquired 58,372 shares (grant or award)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale EVP, CHIEF SCIENTIFIC OFFICER sold 5,145 shares at $10.06 ($51,745)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 18 · 351 filings